Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Chimerix revenue
Chimerix's revenue is $212,000.
What is Chimerix's revenue?
- Chimerix's revenue growth from 2012 to 2024 is -99.37%.
- Chimerix has 82 employees, and the revenue per employee ratio is $2,585.
- Chimerix's peak quarterly revenue was $32.6M in 2022(q3).
- Chimerix peak revenue was $33.8M in 2022.
- Chimerix annual revenue for 2023 was 324.0K, -99.04% growth from 2022.
- Chimerix annual revenue for 2024 was 212.0K, -34.57% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Chimerix historical revenue
Chimerix's peak revenue was $33.8M in 2022. The peak quarterly revenue was $32.6M in 2022(q3).
Chimerix's revenue increased from $33.7m in 2012 to $212.0K currently. That's a -99.37% change in annual revenue.
Chimerix annual revenue
Chimerix annual revenue over time
| Fiscal year / year | Chimerix revenue |
|---|---|
| 2012 | $33.7M |
| 2013 | $4.4M |
| 2014 | $4.0M |
| 2015 | $10.8M |
| 2016 | $5.7M |
| 2017 | $4.5M |
| 2018 | $7.2M |
| 2019 | $12.5M |
| 2020 | $5.4M |
| 2021 | $2.0M |
| 2022 | $33.8M |
| 2023 | $324,000 |
| 2024 | $212,000 |
Rate Chimerix's financial transparency
Chimerix annual growth
Chimerix saw the greatest revenue growth in 2022, when revenue increased by 1,609.15%.
Chimerix had the lowest revenue growth in 2013, when revenue changed by -87.04%.
Chimerix annual growth rate over time
| Year | Chimerix growth |
|---|---|
| 2013 | -87%↓ |
| 2014 | -8%↓ |
| 2015 | 166%↑ |
| 2016 | -47%↓ |
| 2017 | -21%↓ |
| 2018 | 61%↑ |
| 2019 | 73%↑ |
| 2020 | -57%↓ |
| 2021 | -63%↓ |
| 2022 | 1609%↑ |
| 2023 | -99%↓ |
| 2024 | -35%↓ |
Chimerix quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Chimerix quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2012 | - | - | - | $3.6M |
| 2013 | $1.8M | $808,000 | $912,000 | $879,000 |
| 2014 | $780,000 | $919,000 | $1.2M | $1.2M |
| 2015 | $1.2M | $4.1M | $2.3M | $3.1M |
| 2016 | $1.2M | $1.8M | $653,000 | $2.0M |
| 2017 | $1.1M | $675,000 | $897,000 | $1.8M |
| 2018 | $790,000 | $1.2M | $369,000 | $4.9M |
| 2019 | $2.4M | $1.4M | $2.0M | $6.8M |
| 2020 | $1.2M | $1.4M | $1.6M | $1.1M |
| 2021 | $1.4M | $391,000 | $107,000 | $46,000 |
| 2022 | $15,000 | $440,000 | $32.6M | $814,000 |
| 2023 | $283,000 | $26,000 | $11,000 | $4,000 |
| 2024 | - | $129,000 | $26,000 | $57,000 |
Chimerix jobs nearby
Do you work at Chimerix?
Did Chimerix meet its revenue projections?
Chimerix financial information
| CEO | Michael Sherman |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 82 |
| Date Founded | 2000 |
| Headquarters | Durham, North Carolina |
| Number of Locations | 1 |
| Revenue | $212,000 |
| Net Income | $172,167,000 |
| Gross Proft | $33.4M (2022) |
| PE Ratio | -1.10 |
| Tax Rate | -0.0% |
| Market Capitalization | $97.4M |
| Total Assets | $279,341,000 |
| Ticker | CMRX |
Chimerix jobs you might like
Chimerix financing
Chimerix received early financing of $1.0M on 2002-07-22.
| Series | Round size | Date |
|---|---|---|
| Series A | $1M | 07/2002 |
| Series B | $3.1M | 09/2003 |
| Grant | $36.1M | 09/2003 |
| Series C | $11M | 11/2004 |
| Series C | $1.5M | 07/2006 |
| Series D | $23.1M | 02/2007 |
| Series E | $16.1M | 08/2009 |
| Series F | $45M | 02/2011 |
| Post Ipo Equity | $119.4M | 05/2014 |
| Post Ipo Equity | $34.9M | 07/2019 |
| Post Ipo Equity | $100M | 01/2021 |
| Post Ipo Debt | $50M | 02/2022 |
Chimerix investors
| Investors | Security type |
|---|---|
| Asset Management Company | Series A |
| Sanderling Ventures | Series B |
| Asset Management Company | Series B |
| National Institutes of Health (NIH) | Grant |
| Sanderling Ventures | Series C |
| Asset Management Ventures | Series C |
| Frazier Technology Ventures | Series C |
| Asset Management Company | Series C |
| Sanderling Ventures | Series D |
| Canaan Partners | Series D |
| Asset Management Company | Series D |
| Frazier Healthcare Partners | Series D |
| Alta Partners | Series D |
| Asset Management Ventures | Series D |
| Sanderling Ventures | Series E |
| Canaan Partners | Series E |
| Asset Management Company | Series E |
| Alta Partners | Series E |
| Asset Management Ventures | Series E |
| Sanderling Ventures | Series F |
| Canaan Partners | Series F |
| Pappas Ventures | Series F |
| Morningside Group | Series F |
| Frazier Healthcare Partners | Series F |
| Alta Partners | Series F |
| Asset Management Ventures | Series F |
| New Leaf Venture Partners | Series F |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Chimerix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Chimerix. The employee data is based on information from people who have self-reported their past or current employments at Chimerix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Chimerix. The data presented on this page does not represent the view of Chimerix and its employees or that of Zippia.
Chimerix may also be known as or be related to CHIMERIX INC, Chimerix, Chimerix Inc and Chimerix, Inc.